Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model

Infection and Immunity

Volumn 70, Issue 11, 2002, Pages 6489-6493

  Li, Qing ^a   Whalen, Christopher C ^a   Albert, Jeffrey M ^a   Larkin, Rhonda ^a   Zukowski, Lynn ^a   Cave, M Donald ^a   Silver, Richard F ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSERINE; KANAMYCIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; COLONY FORMING UNIT; GENOTYPE; GROWTH RATE; HUMAN; HUMAN CELL; MODEL; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

DRUG RESISTANCE, BACTERIAL; HUMANS; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS;

EID: 0036839651     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.11.6489-6493.2002     Document Type: Article

References (29)

1. Alland, D., G. E. Kalkut, A. R. Moss, R. A. McAdam, J. A. Hahn, W. Bosworth, E. Drucker, and B. R. Bloom. 1994. Transmission of tuberculosis in New York City. N. Engl. J. Med. 330:1710-1716.
2. Barnes, P. F., Z. Yang, S. Preston-Martin, J. M. Pogoda, B. E. Jones, M. Otaya, K. D. Eisenach, L. Knowles, S. Harve, and M. D. Cave. 1997. Patterns of tuberculosis transmission in Central Los Angeles. JAMA 278:1159-1163.
3. Beggs, M. L., K. D. Eisenach, and M. D. Cave. 2000. Mapping of IS6110 insertion sites in two epidemic strains of Mycobacterium tuberculosis. J. Clin. Microbiol. 38:2923-2928.
4. Bifani, P. J., B. Mathema, N. E. Kurepina, and B. N. Kreiswirth. 2002. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 10:45-52.
5. Bifani, P. J., B. B. Plikaytis, V. Kapur, K. Stockbauer, X. Pan, M. L. Lutfey, S. L. Moghazeh, W. Eisner, T. M. Daniel, M. H. Kaplan, J. T. Crawford, J. M. Musser, and B. N. Kreiswirth. 1996. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 275:452-457.
6. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1112.
7. Dale, J. W., D. Brittain, A. A. Cataldi, D. Cousins, J. T. Crawford, J. Driscoll, H. Heersman, T. Lillebaek, T. Quitugua, N. Rastogi, R. A. Skuce, C. Sola, D. Van Soolingen, and V. Vincent. 2001. Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclature. Int. J. Tuberc. Lung Dis. 5:216-219.
8. Daly, C. L., P. M. Small, G. F. Schecter, G. K. Schoolnik, R. A. McAdam, W. R. Jacobs, Jr., and P. C. Hopewell. 1992. An outbreak of tuberculosis with accelerated progression among persons infected with human immunodeficiency virus. N. Engl. J. Med. 326:231-235.
9. Daniel, T. M., J. H. Bates, and K. A. Downes. 1994. History of tuberculosis, p. 13-24. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
10. Douvas, G. S., D. L. Looker, A. E. Vatter, and A. J. Crowle. 1985. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria, Infect. Immun. 50:1-8.
11. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
12. Flynn, J. L. 1999. Why is IFN-gamma insufficient to control tuberculosis? Trends Microbiol. 7:477-478.
13. Hoal-van Helden, E. G., D. Hon, L.-A. Lewis, N. Beyers, and P. D. van Helden. 2001. Mycobacterial growth in human macrophages: variation according to donor, inoculum, and bacterial strain. Cell Biol. Int. 25:71-81.
14. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
15. Laird, N. M., and J. H. Ware. 1982. Random effects models for longitudinal data. Biometrics 38:963-974.
16. Manca, C., L. Tsenova, C. E. Barry III, A. Bergtold, S. Freeman, P. A. Haslett, J. M. Musser, V. H. Freedman, and G. Kaplan. 1999. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 162:6740-6746.
17. Middlebrook, G., and M. L. Cohn. 1953. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science 118:297-299.
18. Mitchison, D. A., J. G. Wallace, A. L. Bhatia, J. B. Selkon, Subbaiah, and M. C. Lancaster. 1960. A comparison of the virulence in guinea pigs of south India and British tubercule bacilli. Tubercle 41:1-22.
19. Ordway, D. J., M. G. Sonnenberg, S. A. Donahue, J. T. Belisle, and I. M. Orme. 1995. Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice. Infect. Immun. 63:741-743.
20. Pelicic, V., M. Jackson, J. M. Reyrat, W. R. Jacobs, Jr., B. Gicquel, and C. Guilhot. 1997. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 94:10955-10960.
21. Rook, G. A., J. Steele, M. Ainsworth, and B. R. Champion. 1986. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant γ-interferon on human monocytes and murine peritoneal macrophages. Immunology 59:333-338.
22. Silver, R. F., Q. Li, and J. J. Ellner. 1998. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect. Immun. 66:1190-1199.
23. Silver, R. F., Q. Li, W. H. Boom, and J. J. Ellner. 1998. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T-cells in PPD-positive but not in PPD-negative subjects. J. Immunol. 160:2408-2417.
24. Small, P. M., P. C. Hopewell, S. P. Singh, A. Paz, J. Parsonnet, D. C. Ruston, G. F. Schecter, C. L. Daley, and G. K. Schoolnik. 1994. The epidemiology of tuberculosis in San Francisco. N. Engl. J. Med. 330:1703-1709.
25. Steenken, J. W. J., and L. U. Gardner. 1946. History of H37 strain of tubercle bacillus. Am. Rev. Tuberc. 54:62-66.
26. Valway, S. E., M. P. Sanchez, T. F. Shinnick, I, Orme, T. Agerton, D. Hoy, J. S. Jones, H. Westmoreland, and I. M. Onorato. 1998. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 338:633-639.
27. van Embden, J. D. A., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, and P. M. Small. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
28. Van Soolingen, D., L. Qian, P. E. W. de Haas, J. T. Douglas, H. Traore, F. Portaels, H. Zi Qing, D. Enkhsaikan, P. Nymadawa, and J. D. A. van Embden. 1995. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J. Clin. Microbiol. 33:3234-3238.
29. Zhang, M., J. Gong, Z. Yang, B. Samten, M. D. Cave, and P. F. Barnes. 1999. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J. Infect. Dis. 179:1213-1217.